Alera Labs is a contract research organization (CRO) providing analytical and pre-formulation support to pharmaceutical, biotech and medical device companies. Alera Labs was founded in 2010 after realization that most larger CROs are not able to accommodate the needs of the small startup companies requiring faster response times and operating with much smaller budgets. It is extremely crucial for a small startup funded by angel or venture capital funds to achieve milestones on time, and even a day delay means a world of difference in the success of the process or formulation, or start of toxicology or clinical studies.
Our company specializes in providing high quality analytical services at a low cost with the fastest turnaround time in the industry at no additional charge. Its founders worked on both sides of the CRO business (as part of a CRO and at pharmaceutical or medical device companies) and know all the shortcomings of the majority of the CROs firsthand.
We are the only company that would provide you with a quotation within 24 hours of your work request.
Starting with a proposal for the work that you require and working with you closely to bring your project to successful closure, we will always ensure timely communication and the most efficient solutions to your problems.
Recent advances and additions to our method portfolio include:
- Quantitative analysis of PEG load on gold nanoparticles down to several molecules per particle
- Quantitative analysis of fatty acids, fatty alcohols/aldehydes, leukotrienes and cholesterol in various matrices from as little as 2 mg of sample
- Extremely sensitive in vitro method for determination of DNA crosslinks using LC-MS, which can be used for screening or optimization of anti-cancer drugs with DNA crosslinking mode of action
- Analysis of metabolic plant intermediates using LC-MS/MS at ppb levels, which is useful in monitoring transgenic plant metabolic pathways
- High throughput HPLC assay for quantitative carotenoid testing from as low as 20mg of plant tissue